Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Kate Johnson

    News

    Online support tool improves AD self-management

    Author:
    Kate Johnson
    Publish date: November 2, 2022

    The intervention, directed either at parents of children with AD or young adults with AD, “is very low cost, evidence based, easily accessible,...

    • Read More

    News

    Plant-based diet cut hot flashes 78%: WAVS study

    Author:
    Kate Johnson
    Publish date: October 27, 2022

    Postmenopausal women who ate a reduced-fat, vegan diet supplemented with soy experienced far fewer hot flashes and improved quality of live,...

    • Read More

    News

    Remote assessment of atopic dermatitis is feasible with patient-provided images: Study

    Author:
    Kate Johnson
    Publish date: October 26, 2022

    Overall, the main problem with remote assessment seems to be the feasibility of patients providing images, according to the investigator.

    • Read More

    News

    Dupilumab-associated ocular surface disease in patients with AD: Unraveling the link

    Author:
    Kate Johnson
    Publish date: October 25, 2022

    In the study, dupilumab treatment was associated with a significant decline in the production of Mucin5AC, suggesting a decline in function of the...

    • Read More

    News

    Evidence mounting that full-body emollients don’t prevent AD in at-risk babies

    Author:
    Kate Johnson
    Publish date: October 24, 2022

    “So far, the science does not look convincing,” said the lead investigator, Dr. Hywel C. Williams.

    • Read More

    News

    Study finds systemic AD treatment relieves depressive symptoms along with skin symptoms

    Author:
    Kate Johnson
    Publish date: October 21, 2022

    MONTREAL – Systemic treatment of atopic dermatitis (AD) boosts mood in addition...

    • Read More

    News

    Increased HIV infection linked to pandemic-related access to PrEP

    Author:
    Kate Johnson
    Publish date: October 7, 2022

    Changes in PrEP access were reported by a total of 109 (13.8%) of baseline respondents.

    • Read More

    News

    Ublituximab bests teriflunomide in head-to-head clinical trials

    Author:
    Kate Johnson

    The results of the ULTIMATE I and II trials may pave the way for ublituximab’s approval as the third high-efficacy anti-CD20 monoclonal antibody...

    • Read More

    News

    VTE risk not elevated in AD patients on JAK inhibitors: Study

    Author:
    Kate Johnson
    Publish date: August 30, 2022

    The labels of JAK inhibitors include a boxed warning describing an increased risk of “serious heart-related events such as heart attack or stroke...

    • Read More

    News

    ‘Flat denial’ can leave breast cancer patients with lasting scars

    Author:
    Kate Johnson
    Publish date: August 26, 2022

    “I’ll just leave a little extra skin, in case you change your mind.”

    • Read More

    News

    Underweight in early childhood persists

    Author:
    Kate Johnson
    Publish date: August 8, 2022

    The findings of a new study ‘highlight the importance of preventing underweight in early life.’

    • Read More

    News

    Injectable HIV prevention better than pills in two trials

    Author:
    Kate Johnson
    Publish date: August 2, 2022

    “The incredible efficacy of long-acting PrEP for cisgender women shown by HPTN 084 is game-changing for our practice.”

    • Read More

    News

    Landmark ALLIANCE results offer tenofovir guidance in HIV/HBV coinfection

    Author:
    Kate Johnson
    Publish date: August 2, 2022

    “There is hardly any good reason to give the two-pill DTG regimen over single-tablet BTG/TAF/FTC in HBV-coinfected people living with HIV.”

    • Read More

    News

    Doxycycline cuts STI risk in men and trans women having sex with men

    Author:
    Kate Johnson
    Publish date: July 29, 2022

    “It is time to take action on the data that we have and really think about incorporating it into guidelines and rolling this out in a safe and...

    • Read More

    News

    Prolonged remission in patient with HIV may open new avenues to functional cure

    Author:
    Kate Johnson
    Publish date: July 29, 2022

    “This case opens new avenues in the HIV functional-cure field.”

    • Read More

    Pages

    • « first
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery